These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25740288)

  • 1. Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant Efficacy.
    Stuart SA; Butler P; Munafò MR; Nutt DJ; Robinson ES
    Neuropsychopharmacology; 2015 Aug; 40(9):2165-74. PubMed ID: 25740288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A translational rodent assay of affective biases in depression and antidepressant therapy.
    Stuart SA; Butler P; Munafò MR; Nutt DJ; Robinson ES
    Neuropsychopharmacology; 2013 Aug; 38(9):1625-35. PubMed ID: 23503126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further validation of the affective bias test for predicting antidepressant and pro-depressant risk: effects of pharmacological and social manipulations in male and female rats.
    Hinchcliffe JK; Stuart SA; Mendl M; Robinson ESJ
    Psychopharmacology (Berl); 2017 Oct; 234(20):3105-3116. PubMed ID: 28735366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural and computational methods reveal differential effects for how delayed and rapid onset antidepressants effect decision making in rats.
    Hales CA; Houghton CJ; Robinson ESJ
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1268-1280. PubMed ID: 29100819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Affective Bias Test and Reward Learning Assay: Neuropsychological Models for Depression Research and Investigating Antidepressant Treatments in Rodents.
    Hinchcliffe JK; Robinson ESJ
    Curr Protoc; 2024 Jun; 4(6):e1057. PubMed ID: 38923877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid-acting antidepressant drugs modulate affective bias in rats.
    Hinchcliffe JK; Stuart SA; Wood CM; Bartlett J; Kamenish K; Arban R; Thomas CW; Selimbeyoglu A; Hurley S; Hengerer B; Gilmour G; Robinson ESJ
    Sci Transl Med; 2024 Jan; 16(729):eadi2403. PubMed ID: 38198569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the medial prefrontal cortex in the effects of rapid acting antidepressants on decision-making biases in rodents.
    Hales CA; Bartlett JM; Arban R; Hengerer B; Robinson ESJ
    Neuropsychopharmacology; 2020 Dec; 45(13):2278-2288. PubMed ID: 32842137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effects of Δ⁹-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression.
    Elbatsh MM; Moklas MA; Marsden CA; Kendall DA
    Pharmacol Biochem Behav; 2012 Aug; 102(2):357-65. PubMed ID: 22634064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
    Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L
    Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system.
    Khakpai F; Ebrahimi-Ghiri M; Alijanpour S; Zarrindast MR
    Biomed Pharmacother; 2019 Apr; 112():108717. PubMed ID: 30970516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat.
    Assareh N; ElBatsh MM; Marsden CA; Kendall DA
    Pharmacol Biochem Behav; 2012 Jan; 100(3):506-12. PubMed ID: 22037406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test.
    Wang X; Yang Y; Zhou X; Wu J; Li J; Jiang X; Qu Q; Ou C; Liu L; Zhou S
    Psychiatry Res; 2011 Jan; 185(1-2):248-53. PubMed ID: 20580983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
    Fedgchin M; Trivedi M; Daly EJ; Melkote R; Lane R; Lim P; Vitagliano D; Blier P; Fava M; Liebowitz M; Ravindran A; Gaillard R; Ameele HVD; Preskorn S; Manji H; Hough D; Drevets WC; Singh JB
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):616-630. PubMed ID: 31290965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
    Brand SJ; Harvey BH
    Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
    Abdallah CG; Sanacora G; Duman RS; Krystal JH
    Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
    Popova V; Daly EJ; Trivedi M; Cooper K; Lane R; Lim P; Mazzucco C; Hough D; Thase ME; Shelton RC; Molero P; Vieta E; Bajbouj M; Manji H; Drevets WC; Singh JB
    Am J Psychiatry; 2019 Jun; 176(6):428-438. PubMed ID: 31109201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.
    Burgdorf J; Zhang XL; Nicholson KL; Balster RL; Leander JD; Stanton PK; Gross AL; Kroes RA; Moskal JR
    Neuropsychopharmacology; 2013 Apr; 38(5):729-42. PubMed ID: 23303054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
    Behav Pharmacol; 2017 Feb; 28(1):1-8. PubMed ID: 27759570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.